Tissue Regenix Group (TRX)

Sector:

Financials

Index:

FTSE AIM All-Share

37.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 74.00
  • 52 Week Low: 36.00
  • Currency: UK Pounds
  • Shares Issued: 71.40m
  • Volume: 3,626
  • Market Cap: £26.42m
  • RiskGrade: 22
  • Beta: 0.00

Latest ShareCast News

Tissue Regenix flags first half in line with expectations

By Josh White

Date: Tuesday 16 Jul 2024

(Sharecast News) - Regenerative medical device company Tissue Regenix reported a strong first-half performance in a trading update on Tuesday, in line with its own expectations.

Tissue Regenix purchases building at Texas site

By Iain Gilbert

Date: Friday 14 Jun 2024

(Sharecast News) - Medical technology company Tissue Regenix has purchased the building it currently leases at its facility in Universal City, Texas.

Tissue Regenix gets approval for Irish hub, inks deal in Spain

By Josh White

Date: Monday 30 Oct 2023

(Sharecast News) - Tissue Regenix announced on Monday that it has won approval from the Irish Health Products Regulatory Authority (HPRA) to establish a logistics hub in Ireland, facilitating the distribution of its allograft products throughout the European Union (EU).

Tissue Regenix signs exclusive distribution deal... 18-Jan-2023 ShareCast
Tissue Regenix strikes distribution deal in Italy 09-Mar-2022 ShareCast
Tissue Regenix makes first delivery of 'OrthoPur... 02-Dec-2020 ShareCast
Tissue Regenix narrows losses in first half 02-Sep-2020 ShareCast
Tissue Regenix enters UK distribution deal for '... 24-Aug-2020 ShareCast
Tissue Regenix to save £0.4m with move across Le... 17-Aug-2020 ShareCast
Tissue Regenix begins capacity expansion in Texas 24-Jul-2020 ShareCast
Tissue Regenix gets another $0.42m under US Covi... 20-Apr-2020 ShareCast
Tissue Regenix shares surge as it bring attack-h... 04-Feb-2020 ShareCast
Tissue Regenix hit by cyber attack 28-Jan-2020 ShareCast
Tissue Regenix warns of lower revenues and EBITDA 17-Oct-2019 ShareCast
Tissue Regenix extends dCELL technology with new... 03-Oct-2019 ShareCast
Mike Barker installed as finance chief at Tissue... 28-Aug-2019 ShareCast
Tissue Regenix signs lease to expand San Antonio... 15-Aug-2019 ShareCast
Tissue Regenix wins extra US coverage for DermaP... 04-Apr-2019 ShareCast
Tissue Regenix eyes profits after revenues more ... 04-Feb-2019 ShareCast
Tissue Regenix CEO to take leave of absence due ... 06-Dec-2018 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

TRX Market Data

Currency UK Pounds
Share Price 37.00p
Change Today -1.00p
% Change -2.63 %
52 Week High 74.00
52 Week Low 36.00
Volume 3,626
Shares Issued 71.40m
Market Cap £26.42m
Beta 0.00
RiskGrade 22

TRX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.21% below the market average25.21% below the market average25.21% below the market average25.21% below the market average25.21% below the market average
34.62% below the sector average34.62% below the sector average34.62% below the sector average34.62% below the sector average34.62% below the sector average
Price Trend
66.89% below the market average66.89% below the market average66.89% below the market average66.89% below the market average66.89% below the market average
76.36% below the sector average76.36% below the sector average76.36% below the sector average76.36% below the sector average76.36% below the sector average
Income Not Available
Growth
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average

TRX Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
15:53 3,600 @ 36.04p
15:27 13 @ 37.90p
08:36 13 @ 36.04p

TRX Key Personnel

CEO Daniel Lee
CFO David Cocke

Top of Page